Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Januar 2015 08:30 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Biopharma Awarded $770,852 by Federal Judge

WILMINGTON, Del., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that after prevailing in a federal lawsuit brought against the...
14. November 2014 16:00 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Biopharma Reports on Annual Stockholder Meeting

PHILADELPHIA, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc. (NYSE MKT:HEB) announced that it held its 2014 Annual Meeting of Stockholders on November 12, 2014. Final voting results will...
30. Oktober 2014 08:30 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Biopharma Reports New Evidence -- Based Potential of Ampligen(R) Against Ebola Virus Disease (EVD)

PHILADELPHIA, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), reported today a new peer reviewed publication entitled, "The Quest for...
20. Oktober 2014 12:00 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC as Governmental Counsel in Fight Against Ebola

PHILADELPHIA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has retained Squire Patton Boggs (SPB) to serve as its global government...